Blodgett Wealth Advisors LLC Lowers Holdings in Procter & Gamble Company (The) $PG

Blodgett Wealth Advisors LLC lowered its position in Procter & Gamble Company (The) (NYSE:PGFree Report) by 3.0% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 6,480 shares of the company’s stock after selling 200 shares during the period. Procter & Gamble comprises approximately 0.8% of Blodgett Wealth Advisors LLC’s investment portfolio, making the stock its 22nd biggest position. Blodgett Wealth Advisors LLC’s holdings in Procter & Gamble were worth $1,032,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of PG. Brighton Jones LLC raised its position in shares of Procter & Gamble by 51.5% in the fourth quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock worth $6,717,000 after acquiring an additional 13,617 shares during the period. Bank Pictet & Cie Europe AG raised its position in shares of Procter & Gamble by 493.6% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 341,750 shares of the company’s stock worth $57,294,000 after purchasing an additional 284,174 shares during the last quarter. Two Sigma Advisers LP raised its position in shares of Procter & Gamble by 100.5% during the 4th quarter. Two Sigma Advisers LP now owns 110,300 shares of the company’s stock worth $18,492,000 after purchasing an additional 55,300 shares during the last quarter. Two Sigma Investments LP raised its position in shares of Procter & Gamble by 2.4% during the 4th quarter. Two Sigma Investments LP now owns 18,133 shares of the company’s stock worth $3,040,000 after purchasing an additional 433 shares during the last quarter. Finally, Westwood Holdings Group Inc. raised its position in shares of Procter & Gamble by 23.4% during the 4th quarter. Westwood Holdings Group Inc. now owns 9,746 shares of the company’s stock worth $1,634,000 after purchasing an additional 1,848 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Buying and Selling at Procter & Gamble

In other news, CEO Jon R. Moeller sold 40,119 shares of the business’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $6,309,515.13. Following the transaction, the chief executive officer directly owned 319,375 shares in the company, valued at $50,228,106.25. The trade was a 11.16% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Shailesh Jejurikar sold 13,039 shares of the business’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the sale, the chief operating officer directly owned 28,036 shares in the company, valued at approximately $4,409,221.72. This represents a 31.74% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 120,181 shares of company stock valued at $18,918,012. Insiders own 0.20% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently weighed in on the stock. JPMorgan Chase & Co. restated a “neutral” rating and set a $170.00 price target (down previously from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. BNP Paribas restated an “outperform” rating and set a $177.00 price target on shares of Procter & Gamble in a research report on Friday, August 15th. Barclays set a $164.00 price target on shares of Procter & Gamble and gave the stock an “equal weight” rating in a research report on Thursday, July 31st. UBS Group set a $180.00 price target on shares of Procter & Gamble and gave the stock a “buy” rating in a research report on Wednesday, July 30th. Finally, Evercore ISI reaffirmed an “in-line” rating and set a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. One equities research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $175.12.

View Our Latest Research Report on Procter & Gamble

Procter & Gamble Price Performance

Shares of NYSE:PG opened at $158.08 on Wednesday. The company’s fifty day moving average price is $156.14 and its 200 day moving average price is $161.62. Procter & Gamble Company has a 12 month low of $149.91 and a 12 month high of $180.43. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. The firm has a market capitalization of $369.98 billion, a P/E ratio of 24.28, a P/E/G ratio of 4.14 and a beta of 0.36.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. The company had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. Procter & Gamble’s quarterly revenue was up 1.7% on a year-over-year basis. During the same period in the previous year, the business posted $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, sell-side analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were paid a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date was Friday, July 18th. Procter & Gamble’s payout ratio is 64.98%.

About Procter & Gamble

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Further Reading

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.